The involvement of HLA-E and -F in pregnancy

Journal of Reproductive Immunology

Volumn 69, Issue 2, 2006, Pages 101-113

  Ishitani, Akiko ^a   Sageshima, Noriko ^a   Hatake, Katsuhiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD94 NKG2; HLA E; HLA F; HLA G; Pregnancy; Trophoblast

Indexed keywords

CD94 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DECIDUA; DOWN REGULATION; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SHORT SURVEY; T LYMPHOCYTE;

DECIDUA; EMBRYONIC DEVELOPMENT; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PREGNANCY; TROPHOBLASTS;

EID: 33644904576     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2005.10.004     Document Type: Short Survey

References (52)

1. A.A. Ashkar, G.P. Black, Q. Wei, H. He, L. Liang, J.R. Head, and B.A. Croy Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy J. Immunol. 171 2003 2937 2944
2. A. Barakonyi, B. Polgar, and J. Szekeres-Bartho The role of gamma/delta T-cell receptor-positive cells in pregnancy. Part II Am. J. Reprod. Immunol. 42 1999 83 87
3. A. Barakonyi, K.T. Kovacs, E. Miko, L. Szereday, P. Varga, and J. Szekeres-Bartho Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy J. Immunol. 168 2002 2683 2688
4. F. Borrego, M. Ulbrecht, E.H. Weiss, J.E. Coligan, and A.G. Brooks Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed cell with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer c ell-mediated lysis J. Exp. Med. 187 1998 813 818
5. V.M. Braud, D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, L.L. Lanier, and A.J. McMichael HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 391 1998 795 799
6. M. Colonna, J. Samaridis, M. Cella, L. Angman, R.L. Allen, C.A. O'Callaghan, R. Dunbar, G.S. Ogg, V. Cerundolo, and A. Rolink Human myelomonocytic cells express an inhibitory receptor for classical and non-classical MHC class I molecules J. Immunol. 160 1998 3096 3100
7. P. Contini, M. Ghio, A. Poggi, G. Filaci, F. Indiveri, S. Ferrone, and F. Puppo Soluble HLA-A,-B -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation Eur. J. Immunol. 33 2003 125 134
8. bright subset Blood 97 2001 3146 3151
9. C.S. Falk, M. Mach, D.J. Schendel, E.H. Weiss, I. Hilgert, and G. Hahn NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation J. Immunol. 169 2002 3257 3266
10. S.M. Fournel, M. Aguerre-Girr, X. Huc, F. Lenfant, A. Alam, A. Toubert, A. Bensussan, and P. Le Bouteiller Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 J. Immunol. 164 2000 6100 6104
11. D.E. Geraghty, B.H. Koller, and H.T. Orr A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment Proc. Natl. Acad. Sci. U.S.A. 84 1987 9145 9149
12. D.E. Geraghty, X.H. Wei, H.T. Orr, and B.H. Koller Human leukocyte antigen F (HLA-F) An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element J. Exp. Med. 171 1990 1 18
13. D.E. Geraghty, M. Stockschleader, A. Ishitani, and J.A. Hansen Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism Hum. Immunol. 33 1992 174 184
14. C. Grimsley, A. Kawasaki, C. Gassner, N. Sageshima, Y. Nose, K. Hatake, D.E. Geraghty, and A. Ishitani Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data Tissue Antigens 60 2002 206 212
15. A.S. Heinzel, J.E. Grotzke, R.A. Lines, D.A. Lewinsohn, A.L. McNabb, D.N. Streblow, V.M. Braud, H.J. Grieser, J.T. Belisle, and D.M. Lewinsohn HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells J. Exp. Med. 196 2002 1473 1481
16. S. Higuma-Myojo, Y. Sasaki, S. Miyazaki, M. Sakai, A. Siozaki, and N. Miwa Cytokine profile of natural killer cells in early human pregnancy Am. J. Reprod. Immunol. 54 2005 21 29
17. N. Hirankarn, I. Kimkong, and A. Mutirangura HLA-E polymorphism in patients with nasopharyngeal carcinoma Tissue Antigens 64 2004 588 592
18. A. Ishitani, and D.E. Geraghty Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens Proc. Natl. Acad. Sci. U.S.A. 89 1992 3947 3951
19. A. Ishitani, N. Sageshima, N. Lee, N. Dorofeeva, K. Hatake, H. Marquardt, and D.E. Geraghty Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition J. Immunol. 171 2003 1376 1384
20. B.K. Kaiser, F. Barahmand-Pour, W. Paulsene, S. Medley, D.E. Geraghty, and R.K. Strong Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics J. Immunol. 174 2005 2878 2884
21. A. King, T.D. Burrows, S.E. Hiby, J.M. Bowen, S. Joseph, S. Verma, P.B. Lim, L. Gardner, P. Le Bouteiller, A. Ziegler, B. Uchanska-Ziegler, and Y.W. Loke Surface expression of HLA-C antigen by human extravillous trophoblast Placenta 21 2000 376 387
22. B.H. Koller, D.E. Geraghty, Y. Shimizu, R. DeMars, and H.T. Orr HLA-E. A novel HLA class I gene expressed in resting T lymphocytes J. Immunol. 141 1988 897 904
23. S. Kovats, E.K. Main, C. Librach, M. Stubblebine, S.J. Fisher, and R. DeMars A class I antigen, HLA-G, expressed in human trophoblasts Science 248 1990 220 223
24. N. Lee, and D.E. Geraghty Genetic diversity of HLA: functional and medical implications
25. N. Lee, D.R. Goodlett, A. Ishitani, H. Marquardt, and D.E. Geraghty HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences J. Immunol. 160 1998 4951 4960
26. N. Lee, M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D.E. Geraghty HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A Proc. Natl. Acad. Sci. U.S.A. 95 1998 5199 5204
27. N. Lee, and D.E. Geraghty HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP J. Immunol. 171 2003 5264 5271
28. E.J. Lepin, J.M. Bastin, D.S. Allan, G. Roncador, V.M. Braud, D.Y. Mason, P.A. van der Merwe, A.J. McMichael, J.I. Bell, S.H. Powis, and C.A. O'Callaghan Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors Eur. J. Immunol. 30 2000 3552 3561
29. J. Li, I. Goldstein, E. Glickman-Nir, H. Jiang, and L. Chess Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E J. Immunol. 167 2001 3800 3808
30. M. Llano, N. Lee, F. Navarro, P. Garcia, J.P. Albar, D.E. Geraghty, and M. Lopez-Botet HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer Eur. J. Immunol. 28 1998 2854 2863
31. M. Llano, M. Guma, M. Ortega, A. Angulo, and M. Lopez-Botet Differential effects of US2 US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets Eur. J. Immunol. 33 2003 2744 2754
32. J. Michaelsson, C. Teixeira de Matos, A. Achour, L.L. Lanier, K. Karre, and K. Soderstrom A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition J. Exp. Med. 196 2002 1403 1414
33. P. Morales, J. Pace, J. Platt, T. Phillips, K. Morgan, A. Fazleabas, and J. Hunt Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype J. Immunol. 171 2003 6215 6224
34. J. Nattermann, H.D. Nischalke, V. Hofmeister, G. Ahlenstiel, H. Zimmermann, L. Leifeld, E.H. Weiss, T. Sauerbruch, and U. Spengler The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells Am. J. Pathol. 166 2005 443 453
35. J. Nattermann, H.D. Nischalke, V. Hofmeister, B. Kupfer, G. Ahlenstiel, G. Feldmann, J. Rockstroh, E.H. Weiss, T. Sauerbruch, and U. Spengler HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells Antivir. Ther. 10 2005 95 107
36. G. Pietra, C. Romagnani, M. Falco, M. Vitale, R. Castriconi, D. Pende, E. Millo, S. Anfossi, R. Biassoni, L. Moretta, and M.C. Mingari The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition Eur. J. Immunol. 31 2001 3687 3693
37. G. Pietra, C. Romagnani, P. Mazzarino, M. Falco, E. Millo, A. Moretta, L. Moretta, and M.C. Mingari HLA-E-restricted recognition of cytomegalovirus- derived peptides by human CD8+ cytolytic T lymphocytes Proc. Natl. Acad. Sci. U.S.A. 100 2003 10896 10901
38. C. Romagnani, G. Pietra, M. Falco, E. Millo, P. Mazzarino, R. Biassoni, A. Moretta, L. Moretta, and M.C. Mingari Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells Proc. Natl. Acad. Sci. U.S.A. 99 2002 11328 11333
39. S. Saito, K. Nishikawa, T. Morii, M. Enomoto, N. Narita, K. Motoyoshi, and M. Ichijo Cytokine production by CD16-CD56 bright natural killer cells in the human early pregnancy decidua Int. Immunol. 5 1993 559 563
40. S. Saito Cytokine network at the feto-maternal interface J. Reprod. Immunol. 47 2000 87 103
41. R. Salerno-Goncalves, M. Fernandez-Vina, D.M. Lewinsohn, and M.B. Sztein Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine J. Immunol. 173 2004 5852 5862
42. S. Sarantopoulos, L. Lu, and H. Cantor Qa-1 restriction of CD8+ suppressor T cells J. Clin. Invest. 114 2004 1218 1221
43. Y. Shimizu, D.E. Geraghty, B.H. Koller, H.T. Orr, and R. DeMars Transfer and expression of three cloned human non-HLA-A, B, C class I major histocompatibility complex genes in mutant lymphoblastoid cells Proc. Natl. Acad. Sci. U.S.A. 85 1988 227 231
44. M. Shiroishi, K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V.M. Braud, D.S. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, E.Y. Jones, P.A. van der Merwe, I. Kumagai, and K. Maenaka Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G Proc. Natl. Acad. Sci. U.S.A. 100 2003 8856 8861
45. C.M. Solier, M. Aguerre-Girr, F. Lenfant, A. Campan, A. Berrebi, V. Rebmann, H. Grosse-Wilde, and P. Le Bouteiller Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast Eur. J. Immunol. 32 2002 3576 3586
46. R.K. Strong, M.A. Holmes, P. Li, L. Braun, N. Lee, and D.E. Geraghty HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities J. Biol. Chem. 278 2003 5082 5090
47. P. Tomasec, V.M. Braud, C. Rickards, M.B. Powell, B.P. McSharry, S. Gadola, V. Cerundolo, L.K. Borysiewicz, A.J. McMichael, and G.W. Wilkinson Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 287 2000 1031 1033
48. A. Trundley, and A. Moffet Human uterine leukocytes and pregnancy Tissue Antigens 63 2004 1 12
49. M. Ulbrecht, S. Modrow, R. Srivastava, P.A. Peterson, and E.H. Weiss Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation J. Immunol. 160 1998 4375 4385
50. M. Vales-Gomez, H.T. Reyburn, R.A. Erskine, M. Lopez-Botet, and J.L. Strominger Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E EMBO J. 49 1999 843 850
51. J.J. Van Rood, and F. Claas Both self and non-inherited maternal HLA antigens influence the immune response Immunol. Today 21 2000 269 273
52. S.D. Wainwright, P.A. Biro, and C.H. Holmes HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern J. Immunol. 164 2000 319 328